TMX Newsfile

IN THE PRESS

Marvel Highlights New Published Research of Its SAB Member Professor David Blum

July 9, 2024

·

4 min read

Optimind Pharma Closes First Tranche of Private Placement

July 8, 2024

·

2 min read

ME Therapeutics Announces New Collaboration with NanoVation Therapeutics on Advanced Therapeutic mRNA Delivery to Myeloid Cells

July 8, 2024

·

4 min read

FSD Pharma Files Amended and Restated Material Change Report

July 8, 2024

·

13 min read

Defence Receives No Objection Letter from Health Canada for Phase I Trial of Its ACCUM-002 (AccuTOX) as an Anti-Cancer Molecule in Patients with Melanoma

July 8, 2024

·

4 min read

CBIH: Unleashing the Potential of Cannabis for Tomorrow’s Medicine

July 8, 2024

·

5 min read

Phio Pharmaceuticals Terminates Share Purchase Agreement with Triton Funds

July 8, 2024

·

1 min read

Phio Pharmaceuticals Announces Addition of Clinical Trial Site for its Phase 1b study of PH-762

July 8, 2024

·

4 min read

Optimind Pharma - Private Placement

July 3, 2024

·

2 min read

Stonegate Updates Coverage on Burcon Nutrascience Corporation (BU)

July 2, 2024

·

1 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750